Avidity Biosciences’ (NASDAQ:RNA) stock experienced a significant surge in premarket trading on Monday, October 27, 2025, following an announcement of a landmark acquisition deal with pharmaceutical giant Novartis […]
crypto news aggregator
Avidity Biosciences’ (NASDAQ:RNA) stock experienced a significant surge in premarket trading on Monday, October 27, 2025, following an announcement of a landmark acquisition deal with pharmaceutical giant Novartis […]